Clinical Trial Update: Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study [NA]

View source ↗

Summary

This entry reports a completed clinical trial (TARGET) evaluating technology-enhanced germline evaluation for therapy in various stages of prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biochemically Recurrent Prostate Cancer
• Prostate Cancer
• Prostate Cancer Ajcc V8
• Stage Iiib Prostate Cancer Ajcc V8
• Stage Iiic Prostate Cancer Ajcc V8

Snippet

Sponsor: Thomas Jefferson University | Conditions: Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma | NA | Status: COMPLETED